We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+5.52%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$5.65B
AUM Growth
+$471M
(+9.1%)
Cap. Flow
+$283M
Cap. Flow
% of AUM
5.01%
Top 10 Holdings %
Top 10 Hldgs %
17.56%
Holding
1,507
New
476
Increased
192
Reduced
202
Closed
448
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lockheed Martin
LMT
|
+$14.4M |
| 2 |
argenx
ARGX
|
+$13.4M |
| 3 |
Compañía de Minas Buenaventura
BVN
|
+$13.1M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$11.3M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KraneShares CSI China Internet ETF
KWEB
|
+$16.7M |
| 2 |
Sabre
SABR
|
+$12.5M |
| 3 |
UBS Group
UBS
|
+$10.2M |
| 4 |
Walt Disney
DIS
|
+$9.97M |
| 5 |
CBL
CBL Properties
CBL
|
+$7.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.56% |
| 2 | Technology | 1.89% |
| 3 | Consumer Discretionary | 0.9% |
| 4 | Communication Services | 0.87% |
| 5 | Industrials | 0.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
SoFi Technologies
SOFI
$21B
| $612K | 0.01% |
73,407
-108,080
| -60% | -$705K |
|
777
Evolus
EOLS
$385M
| $611K | 0.01% |
+84,000
| New | +$725K |
|
778
CALL
Arcus Biosciences
RCUS
$3.55B
| $609K | 0.01% |
30,000
-30,000
| -50% | -$571K |
|
|
779
PUT
Arcus Biosciences
RCUS
$3.55B
| $609K | 0.01% |
30,000
-50,000
| -63% | -$952K |
|
|
ACH
780
Accendra Health
ACH
$237M
| $609K | 0.01% |
32,000
+7,500
| +31% | +$134K |
|
|
FTCH
781
PUT
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $604K | 0.01% |
+100,000
| New | +$482K |
|
782
Elanco Animal Health
ELAN
$13.2B
| $604K | 0.01% |
60,000
+18,600
| +45% | +$173K |
|
783
PUT
Patterson-UTI
PTEN
$3.98B
| $599K | 0.01% |
+50,000
| New | +$564K |
|
|
MRSN
784
DELISTED
Mersana Therapeutics
MRSN
| $595K | 0.01% |
7,240
-4,596
| -39% | -$672K |
|
785
Five Below
FIVE
$12B
| $590K | 0.01% |
3,000
| – | – |
|
786
CALL
SkinHealth Systems
SKIN
$88.8M
| $586K | 0.01% |
+70,000
| New | +$727K |
|
787
Stem
STEM
$48.4M
| $578K | 0.01% |
+5,050
| New | +$501K |
|
788
CALL
Invesco Mortgage Capital
IVR
$759M
| $574K | 0.01% |
50,000
| – | – |
|
789
CALL
Exelixis
EXEL
$13.3B
| $573K | 0.01% |
30,000
-120,000
| -80% | -$2.31M |
|
|
790
PUT
Exelixis
EXEL
$13.3B
| $573K | 0.01% |
30,000
-85,000
| -74% | -$1.64M |
|
791
PUT
Editas Medicine
EDIT
$396M
| $570K | 0.01% |
69,200
| – | – |
|
|
IMGN
792
DELISTED
Immunogen Inc
IMGN
| $566K | 0.01% |
+30,000
| New | +$354K |
|
793
CALL
First Majestic Silver
AG
$7.41B
| $565K | 0.01% |
100,000
| – | – |
|
|
AKRO
794
DELISTED
Akero Therapeutics
AKRO
| $565K | 0.01% |
12,100
-10,060
| -45% | -$461K |
|
795
Guidewire Software
GWRE
$12.6B
| $563K | 0.01% |
7,400
| – | – |
|
796
Corebridge Financial
CRBG
$14.1B
| $558K | 0.01% |
+31,619
| New | +$527K |
|
797
CALL
AnaptysBio
ANAB
$1.58B
| $549K | 0.01% |
27,000
-3,000
| -10% | -$60.8K |
|
|
798
PUT
AnaptysBio
ANAB
$1.58B
| $549K | 0.01% |
27,000
-3,000
| -10% | -$60.8K |
|
799
Yelp
YELP
$1.45B
| $546K | 0.01% |
+15,000
| New | +$484K |
|
800
CALL
BioXcel Therapeutics
BTAI
$24.9M
| $545K | 0.01% |
5,113
+3,238
| +173% | +$1.08M |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q2 2023 Portfolio in Review
As of Q2 2023, Caption Management held 1,507 positions worth $5.65B, up 9.1% from $5.18B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Caption Management deployed $283M of net new capital in Q2 2023, opening 476 new positions and adding to 192 existing holdings. Its largest new stake was Lockheed Martin: 31,000 shares worth $14.3M.
By sector, the portfolio is most concentrated in Healthcare at 2.6% of assets, up from 2% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Sabre, an estimated $12.5M trimmed.
- Caption Management's largest Q2 2023 buy was Lockheed Martin: 31,000 shares worth $14.3M.
- Caption Management added most to State Street SPDR S&P Biotech ETF in Q2 2023, an estimated $11M increase.
- Caption Management's biggest Q2 2023 reduction was Sabre, cutting an estimated $12.5M.
- Caption Management fully exited KraneShares CSI China Internet ETF in Q2 2023, selling an estimated $16.7M.
- Caption Management's ten largest holdings make up 18% of its $5.65B portfolio in Q2 2023.
- Caption Management opened 476 new positions and closed 448 in Q2 2023.
- Caption Management's portfolio value rose 9.1% quarter-over-quarter to $5.65B.
Based on Caption Management's 13F filing for Q2 2023, filed 14 Aug 2023.